Making Decisions About Depression Medications (iADAPT)

Victor Montori

Status

Completed

Conditions

Depression

Treatments

Other: Decision Aid

Study type

Interventional

Funder types

Other

Other U.S. Federal agency

Identifiers

NCT01502891

11-003507

Details and patient eligibility

About

The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medication treatment.

Full description

To determine the ability of decision aids to effectively translate a depression comparative effectiveness research (CER) review into practice, the investigators have developed a literacy-sensitive depression treatment decision aid, DEPRESSION MEDICATION CHOICE, which adapts the Agency for Healthcare Research and Quality (AHRQ)'s Effective Healthcare comparative effectiveness review and associated patient guide about antidepressant medicines to satisfy the needs of clinicians, patients, and other major stakeholders. The investigators will conduct a randomized study to estimate the effect of the decision aid on patient knowledge, patient involvement in decision making and decision-making quality, and on three and six-month measures of medication adherence and mental health, when compared with usual care.

Enrollment

301 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Presumed diagnosis of depression (PHQ-9 of 10 or greater)
As judged by clinician, need to initiate drug treatment for depression
Identify primary care clinician as main depression provider
Agree to be available for follow-up survey 6 months after treatment decision

Exclusion criteria

Has prior diagnosis of bipolar disorder
Has major communication barrier (severe hearing/vision impairment, dementia, cannot communicate with clinician in same language)